Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of the use of oral aprepitant in
combination with intravenous ondansetron and dexamethasone with the efficacy provided by the
use of oral aprepitant and dexamethasone for preventing vomiting during the first 24-48 hours
after breast surgery.